Airway bacterial microbiome signatures correlate with occupational pneumoconiosis progression

Huimin Ma1, Zheng Dong2, Xu Zhang3

  • 1Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China; School of Stomatology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China; Department of Stomatology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.

Insights

Occupational pneumoconiosis (OP) patients show altered respiratory bacterial communities, potentially linked to particulate matter (PM) exposure. Specific bacteria may serve as markers for disease progression.

Area of Science:

  • Microbiology
  • Pulmonary Medicine
  • Environmental Health

Background:

  • The human microbiome plays a crucial role in respiratory health and disease.
  • Knowledge gaps exist regarding the link between bacterial communities and particulate matter (PM)-induced respiratory issues.

Purpose of the Study:

  • To characterize the respiratory bacterial microbiome in occupational pneumoconiosis (OP) patients.
  • To investigate the association between respiratory microbiota and PM exposure in OP.

Main Methods:

  • Respiratory samples were collected from different airway sites of OP patients.
  • Bacterial microbiome composition and function were analyzed using sequencing data.
  • Associations between bacterial communities and disease indicators were examined.

Main Results:

  • OP patients displayed distinct respiratory microbiota dysbiosis compared to healthy individuals.
  • Increased colonization by bacteria like Streptococcus was observed, possibly due to PM intrusion.
  • Smoking significantly impacted microbiome alterations in OP patients.

Conclusions:

  • The bacterial microbiome is implicated in the pathogenesis of PM-induced respiratory diseases.
  • Specific bacterial species (Prevotella, Actinobacillus, Leptotrichia) may serve as biomarkers for OP progression.
  • Findings support the development of microbiome-based diagnostics for PM-related disorders.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
237
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K